Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.75 GBX | 0.00% | +4.17% | -37.50% |
05-08 | Hellenic Dynamics and Ondine Biomedical raise funds | AN |
04-22 | Acuity RM launches counterterrorism risk management Storm in UK | AN |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 1.859 | 1.239 | 1.239 | 1.672 | 2.414 | 3.568 |
Enterprise Value (EV) 1 | -0.1003 | 1.062 | 1.143 | 1.181 | 1.853 | 3.346 |
P/E ratio | 3.26 x | -2.5 x | -16.7 x | -1.35 x | -4.78 x | -10.5 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 13.5 x | - | 620 x | 139 x | 54.9 x | 59.5 x |
EV / Revenue | -0.73 x | - | 572 x | 98.4 x | 42.1 x | 55.8 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | 0.61 x | -39.2 x | -11 x | -9.83 x | -13.6 x | -13.8 x |
FCF Yield | 164% | -2.55% | -9.12% | -10.2% | -7.36% | -7.26% |
Price to Book | 1.05 x | 0.97 x | 1.03 x | 1.1 x | 1.56 x | 2.91 x |
Nbr of stocks (in thousands) | 12,391 | 12,391 | 12,391 | 34,482 | 41,982 | 41,982 |
Reference price 2 | 0.1500 | 0.1000 | 0.1000 | 0.0485 | 0.0575 | 0.0850 |
Announcement Date | 18-06-13 | 19-06-06 | 20-06-09 | 21-05-21 | 22-04-26 | 23-05-25 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 0.138 | - | 0.002 | 0.012 | 0.044 | 0.06 |
EBITDA | - | - | - | - | - | - |
EBIT 1 | -0.131 | -0.093 | 0.062 | -0.149 | -0.239 | -0.256 |
Operating Margin | -94.93% | - | 3,100% | -1,241.67% | -543.18% | -426.67% |
Earnings before Tax (EBT) 1 | 0.604 | -0.498 | -0.072 | -0.757 | -0.422 | -0.341 |
Net income 1 | 0.572 | -0.498 | -0.072 | -0.757 | -0.422 | -0.341 |
Net margin | 414.49% | - | -3,600% | -6,308.33% | -959.09% | -568.33% |
EPS 2 | 0.0460 | -0.0400 | -0.006000 | -0.0360 | -0.0120 | -0.008122 |
Free Cash Flow 1 | -0.1646 | -0.0271 | -0.1042 | -0.1201 | -0.1364 | -0.243 |
FCF margin | -119.29% | - | -5,212.5% | -1,001.04% | -309.94% | -405% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 18-06-13 | 19-06-06 | 20-06-09 | 21-05-21 | 22-04-26 | 23-05-25 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 1.96 | 0.18 | 0.1 | 0.49 | 0.56 | 0.22 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | -0.16 | -0.03 | -0.1 | -0.12 | -0.14 | -0.24 |
ROE (net income / shareholders' equity) | 32.5% | -32.7% | -5.81% | -55.6% | -27.5% | -24.6% |
ROA (Net income/ Total Assets) | -2.49% | -3.33% | 2.79% | -6.51% | -9.4% | -11.1% |
Assets 1 | -22.99 | 14.96 | -2.585 | 11.62 | 4.488 | 3.062 |
Book Value Per Share 2 | 0.1400 | 0.1000 | 0.1000 | 0.0400 | 0.0400 | 0.0300 |
Cash Flow per Share 2 | 0.1600 | 0.0100 | 0.0100 | 0.0100 | 0.0100 | 0.0100 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 18-06-13 | 19-06-06 | 20-06-09 | 21-05-21 | 22-04-26 | 23-05-25 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- ENGI Stock
- Financials ACUY RMPAR